Recruiting PHASE2 INTERVENTIONAL 3-arm NCT05871307

Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases (Radcav)

Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases - A Prospective Randomized Explorative Phase II Trial

Sponsor: University Hospital Heidelberg

Conditions Brain Metastases Radiotherapy

Interventions Intraoperative Radiation Postoperative Radiotherapy Preoperative Radiotherapy

Updated 5 times since 2023 Last updated: May 7, 2024 Started: Feb 1, 2024 Primary completion: May 1, 2026 Completion: May 1, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Brain Metastases and Radiotherapy, this trial is actively recruiting participants. The trial is conducted by University Hospital Heidelberg and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Feb 2024 — Jun 2024 [monthly]

Not Yet Recruiting PHASE2
Jun 2023 — Feb 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Heidelberg

Data source: University Hospital Heidelberg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Heidelberg, Germany